Abstract
DPP-4 inhibition is an incretin-based therapy that works on the principle of stopping the degradation of glucagon-like polypeptide-1 (GLP-1) and gastr......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
